论文部分内容阅读
目的观察奥扎格雷钠注射液治疗急性脑梗死的疗效。方法选择我科收治的急性脑梗死患者98例,随机分为治疗组52例和对照组46例。治疗组给予奥扎格雷钠注射液治疗,对照组则予以舒血宁治疗,连用2周,观察两组患者治疗前后神经功能缺损评分和临床疗效。结果两组患者治疗后1周神经功能缺损评分差异无统计学意义(P>0.05),治疗2周神经功能缺损评分差异有统计学意义(P<0.05)。两组有效率差异也有统计学意义(P<0.05)。结论奥扎格雷钠注射液治疗急性脑梗死,有助于神经功能的改善,可以提高疗效,改善预后。
Objective To observe the efficacy of sodium ozagrel in the treatment of acute cerebral infarction. Methods A total of 98 acute cerebral infarction patients admitted to our department were randomly divided into treatment group (n = 52) and control group (n = 46). The treatment group was given sodium ozagrel injection, while the control group was treated with Shuxuening for 2 weeks. The scores of neurological deficits and clinical efficacy before and after treatment were observed in both groups. Results There was no significant difference in neurological deficit scores between the two groups at 1 week after treatment (P> 0.05). There was significant difference in neurological deficit score between the two groups (P <0.05). The difference between the two groups was also statistically significant (P <0.05). Conclusion Ozagrel sodium injection in the treatment of acute cerebral infarction contributes to the improvement of neurological function, which can improve the curative effect and improve the prognosis.